Jade Biosciences, Inc. (JBIO) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$94.69M | -33.0% |
| 2024 | -$71.20M | -25.4% |
| 2023 | -$56.78M | -45.1% |
| 2022 | -$39.12M | -42.8% |
| 2021 | -$27.40M | -248.6% |
| 2020 | -$7.86M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$94.69M | -33.0% |
| 2024 | -$71.20M | -25.4% |
| 2023 | -$56.78M | -45.1% |
| 2022 | -$39.12M | -42.8% |
| 2021 | -$27.40M | -248.6% |
| 2020 | -$7.86M | — |